非阻害性冠動脈疾患における胸痛パターンと冠動脈微血管機能
Kai Nogami1, Yoshihisa Kanaji2, Takumi Toya3
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
まとめ
運動による胸痛 (CP) と冠動脈微小血管機能障害 (CMD) の患者は微小血管機能が悪化します. 内皮に依存しないCMDは,運動性CP患者の予後に影響を及ぼし,ターゲットを絞った治療を提案する.
科学分野:
- 心臓病科
- 血管医学
- 診断用イメージング
背景:
- 冠動脈微小動脈機能障害 (CMD) は,胸痛と非阻塞性冠動脈の患者 (ANOCA) の主要な原因です.
- ANOCA患者におけるCMDパターンとCP特性の正確な関係は不明である.
研究 の 目的:
- ANOCA患者におけるCMDと異なるCPパターン (運動対休息) の関連性を調査する.
- これらの関連性の予測的意義を評価する.
主な方法:
- 1,264人のANOCA患者は冠動脈反応性検査を受けた.
- 胸の痛みパターンは 運動,休息,または両方に分類されました.
- 内皮依存性および内皮独立性CMDは,冠内アセチルコリンおよびアデノシン輸液を用いて評価された.
主要な成果:
- 運動性CP患者では,静止状態のCP患者と比較して,冠動脈流量リザーブ (CFR) が低く,内皮独立性CMDの発生率が高かった.
- アセチルコリンに対する冠動脈血流 (CBF) の有意な鈍化が運動性CP患者で観察された.
- 7年間の追跡調査で,内皮に依存しないCMDは,運動性CP患者での死亡リスク増加と関連していたが,休息性CP患者ではそうではなかった.
結論:
- ANOCA患者における運動性CPは,休息性CPと比較して微小血管機能の低下と関連しています.
- 内皮に依存しないCMDは,運動性CPの患者にとって有意な予後を伴う.
- CMDの標的治療戦略は,運動性CPを経験するANOCA患者にとって特に有益である可能性があります.
関連する概念動画
01:29Angina III: Clinical Manifestations and Assessment
25
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
25
01:30Coronary Artery Disease III: Clinical Manifestations
31
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
31
01:30Angina I: Introduction
35
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
35
01:27Angina II: Classification
38
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
38
01:27Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
45
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
45